Long-term Effects of HPV Vaccine in Females
The HPV vaccine is becoming increasingly important for women of all ages to protect against the human papillomavirus (HPV). HPV is a common virus that can cause cervical cancer and other types of cancer and health problems. The HPV vaccine is recommended for females between the ages of 9 and 26 and is known to be safe and effective in preventing HPV infections. It is recommended for females between the ages of 9 and 16 and, most commonly, for girls around the age of 11 to receive this vaccine. However, there is still much to learn about the long-term effects of the HPV vaccine in females. Recent research and studies have sought to answer this question, providing insight into the potential long-term effects of the HPV vaccine in females. In this blog post, we’ll take a closer look at the potential long-term effects of the HPV vaccine in females.
Side effects of HPV vaccine in females
By reducing your risk of contracting any of the over 200 strains of HPV, The HPV vaccine in females will assist you in getting better protected against HPV-related cancers. As with any medication, there is, however, the possibility that you may experience side effects from your HPV vaccine, including pain, redness, or swelling in the arm where the shot was administered; fever; dizziness or fainting; nausea; headache or feeling tired; and pain in your muscles or joints.
Almost every vaccination causes these symptoms, which are temporary and show that your immune system is responding. Fortunately, these symptoms are usually mild and resolve within 48 hours of receiving the shot. But what are the long-term effects of the HPV vaccine in females? Since the risk of HPV infection persists throughout a woman’s sexual lifetime, it is important to examine the long-term impact of HPV prevention. In the following sections, we will take a look at it in more detail.
HPV vaccine in females & its long-term effects
Several studies have been conducted in different countries to examine the long-term effects of the HPV vaccine in females in different parts of the world. The vaccine has been associated with a variety of side effects in some countries, which has prompted researchers to conduct long-term surveillance and studies on individuals who have received these three types of vaccinations in different doses. In the following, we discuss some of these studies, the reported long-term side effects, and the relevant research findings.
Adverse Autoimmune Reactions
Italy, Japan, Australia, Columbia, India, Ireland, Denmark, Mexico, Norway, Sweden, Canada, France, the USA, and the United Kingdom have published recent papers on HPV vaccination that share common clinical features with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), fibromyalgia (FM), postural orthostatic tachycardia syndrome (POTS), complex regional pain syndrome (CRPS), small fiber neuropathy (SFN), and autonomic dysfunction (AD). There are typical symptoms of prolonged generalized fatigue, chronic headaches, widespread generalized pain, tremors, orthostatic fainting, postural tachycardia, altered gastrointestinal motility, gait disturbances, anxiety, paresthesias, sleep disturbances, learning impairments, and concentration difficulties.
Their research and surveys on many cases concluded that, at first glance, one might think an adverse autoimmune reaction to HPV vaccine materials caused this patient’s illness. As a result, it is well known that other vaccines, such as influenza and hepatitis B, are also known to be potential initiators of various autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Guillain-Barre Syndrome (GBS). Similarly, HPV vaccine materials have been implicated in the development of CFS/ME, FM, POTS, CRPS, SFN, and AD.
However, these reports cannot be exaggerated and considered a serious problem for this vaccine; Because all vaccines have their side effects.
Adverse Events of Special Interest
Another study in Australia focuses on adverse events following vaccination with 4vHPV from 11 years of post-marketing data, focusing on enhanced surveillance and adverse events of special interest.
Symptoms & illnesses reported included syncope, venous thromboembolism (VTE), anaphylaxis, autoimmune disease (AID), POTS, CRPS, and Guillain-Barré syndrome.
Despite this, over 11 years, reporting rates of AE following 4vHPV administration in Australia were consistent with data from similar surveillance systems internationally and did not yield any new or concerning results.
HPV Vaccine in Females & Cancers
HPV-related cervical cancer is the biggest threat to females, but oropharyngeal cancer, or cancer of the mouth and throat, is also a cause for concern. In addition to the other cancers caused by HPV, oral cancer does not have routine screenings that can detect the disease in its earliest stages. Oral cancer is most commonly caused by HPV infection. Approximately 1 in 140 women will develop oral cancer in their lifetime, and HPV-related oropharyngeal cancers are on the rise.
This list includes the other three cancers which HPV can cause, which occur less frequently than cervical cancer and oral cancer, but which can be just as deadly as cervical and oral cancer:
- Anal cancer accounts for 90% of the 9,440 cases and 1,670 deaths each year.
- Vaginal cancer accounts for 75% of the 8,180 cases and 1,530 deaths each year.
- Vulvar cancer accounts for 70% of the 6,330 cases and 1,560 deaths each year.
There is a risk of death associated with these cancers; however, research has demonstrated that the HPV vaccine has been useful in preventing these cancers, which is one of the long-term effects of the vaccine in females.
The Infertility Worries
Most women think the HPV vaccine causes infertility by causing premature ovarian failure, which is a myth. There has been a great deal of research in this field, and the purpose of these studies was to determine whether or not the receipt of the HPV vaccination is associated with infertility.
Six hundred-eight articles were reviewed in a systematic review of HPV vaccines and infertility. Reviewers concluded that there is no evidence that HPV vaccination is associated with infertility or primary ovarian insufficiency. So, Women who received the HPV vaccine did not experience an increase in infertility due to the vaccination. These results give providers more confidence in recommending HPV vaccinations.
Safety of HPV Vaccine in females
In many parts of the world, the HPV vaccine has been used successfully for many years to prevent cervical cancer. Vaccinations have been administered to more than 100 million people worldwide.
For many years, several authorities have closely monitored the use of the HPV vaccine, including the Centers for Disease Control and Prevention in the US, the World Health Organization (WHO), and the European Medicines Agency (EMA).
Even though they use a variety of safety data, they continue to assert that the HPV vaccine is very safe. There’s no point in using a vaccine unless scientific tests, called clinical trials, show it’s safe and effective and the benefits outweigh the risks.
Afterward, the data from these trials are reviewed by a committee; if the committee confirms the vaccine’s safety, it grants its license. Despite this, these authorities do not rule out the possibility of side effects; however, these side effects are not sufficient to prevent its use.
Prohibition of Getting HPV Vaccination
The vaccination is generally safe, but only people with severe allergies to any HPV vaccine component shouldn’t receive it. The symptoms of a severe allergic reaction may include hives, swelling of the face and throat, trouble breathing, a rapid heart rate, dizziness, and weakness.
Types of HPV vaccination
In addition to examining the long-term effect of the HPV vaccine in women and girls, it’s worth noting that to prevent cervical cancer, three types of HPV vaccines are usually used worldwide:
- The bivalent vaccine (Cervarix®);
- The Four-valent HPV vaccine (Gardasil®);
- The Gardasil 9® vaccine
To calculate how effective each vaccine is, several clinical trials have been conducted to date for each vaccine. According to the results, a wide range of efficacy depends on the vaccine used and the target age.
Additionally, you can read associated articles and research—which, incidentally, are also available on the Internet—to analyze the impacts of a particular vaccine of choice or the target age range if you’re interested in knowing more about the effectiveness of each vaccine.
A few tips about types of HPV vaccine
Yet, here, we want to emphasize that each of the aforementioned vaccines has several benefits, which have led to their widespread acceptance and usage in HPV prevention by various nations across the world.
But it is important to note that one drawback of these vaccines, which are available almost in most developed countries, is that they are expensive for developing nations. Because of this, the public can no longer easily access these well-known and helpful vaccines, and everyone will need help to take advantage of their long-term beneficial effects.
Here, developing countries may make use of OBP’s services and goods. This company has begun manufacturing the biosimilar of the most popular and in-demand vaccinations in the world, including Cervarix, which is designed to treat HPV disease, thanks to its cutting-edge machinery and technology. OBP goods are just as high-quality as the original vaccine samples while costing significantly less, allowing developing nations to take advantage of this upgraded technology at a lesser expense.
There is a lot of evidence that vaccines are very effective in different countries, indicating long-term effects in women. As we move forward, we’d like to examine what other differences HPV has made. There is much evidence that the vaccine is making a difference over time. Many studies have investigated the effectiveness of this vaccine. A significant reduction has been observed in the rates of infection with the two main cancer-causing HPV types in women and in the number of young people with genital warts. On the other hand, vaccinating women has been found to reduce the risk of severe cervical abnormalities by 89% in a recent Scottish study. It’s worth noting that according to some programs, hundreds of cervical cancer deaths will be prevented each year due to the program.